Original Research
Published on 07 Oct 2020
Treatment of Pneumococcal Infection by Using Engineered Human C-Reactive Protein in a Mouse Model
in Molecular Innate Immunity

- 3,035 views
- 5 citations
Original Research
Published on 07 Oct 2020
in Molecular Innate Immunity

Review
Published on 07 Oct 2020
in Molecular Innate Immunity

Brief Research Report
Published on 07 Oct 2020
in Multiple Sclerosis and Neuroimmunology

Original Research
Published on 07 Oct 2020
in Molecular Innate Immunity

Review
Published on 07 Oct 2020
in Comparative Immunology

Original Research
Published on 07 Oct 2020
in Cancer Immunity and Immunotherapy

Methods
Published on 07 Oct 2020
in Autoimmune and Autoinflammatory Disorders

Original Research
Published on 07 Oct 2020
in Cancer Immunity and Immunotherapy

Review
Published on 07 Oct 2020
in Vaccines and Molecular Therapeutics

Original Research
Published on 07 Oct 2020
in Autoimmune and Autoinflammatory Disorders

Mini Review
Published on 07 Oct 2020
in Multiple Sclerosis and Neuroimmunology

Review
Published on 07 Oct 2020
in Immunological Memory

Original Research
Published on 07 Oct 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 06 Oct 2020
in Cancer Immunity and Immunotherapy

Review
Published on 06 Oct 2020
in Microbial Immunology

Review
Published on 06 Oct 2020
in Immunological Memory
